共 68 条
- [1] Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, 362, 6423, pp. 801-809, (1993)
- [2] Herrmann J., Lerman L.O., Rodriguez-Porcel M., Holmes Jr. D.R., Richardson D.M., Ritman E.L., Et al., Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia, Cardiovasc Res, 51, 4, pp. 762-766, (2001)
- [3] Sluimer J.C., Daemen M.J., Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis, J Pathol, 218, 1, pp. 7-29, (2009)
- [4] Virmani R., Burke A.P., Farb A., Kolodgie F.D., Pathology of the vulnerable plaque, J Am Coll Cardiol, 47, 8 SUPPL., (2006)
- [5] Cyrus T., Winter P.M., Caruthers S.D., Wickline S.A., Lanza G.M., Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy, Expert Rev Cardiovasc Ther, 3, 4, pp. 705-715, (2005)
- [6] Winter P.M., Cai K., Caruthers S.D., Wickline S.A., Lanza G.M., Emerging nanomedicine opportunities with perfluorocarbon nanoparticles, Expert Rev Med Devices, 4, 2, pp. 137-145, (2007)
- [7] Sosnovik D.E., Molecular imaging in cardiovascular magnetic resonance imaging: current perspective and future potential, Top Magn Reson Imaging, 19, 1, pp. 59-68, (2008)
- [8] Botnar R.M., Buecker A., Wiethoff A.J., Parsons Jr. E.C., Katoh M., Katsimaglis G., Et al., In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent, Circulation, 110, 11, pp. 1463-1466, (2004)
- [9] Botnar R.M., Perez A.S., Witte S., Wiethoff A.J., Laredo J., Hamilton J., Et al., In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent, Circulation, 109, 16, pp. 2023-2029, (2004)
- [10] Katoh M., Haage P., Wiethoff A.J., Gunther R.W., Bucker A., Tacke J., Et al., Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study, Invest Radiol, 44, 3, pp. 146-150, (2009)